Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Qiagen NV QGEN

Technology Scientific & Technical Instruments
Qiagen NV is a holding company based in the Netherlands. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic... see more

Recent & Breaking News (NYSE:QGEN)

QIAGEN expands QIAstat-Dx syndromic testing menu and announces launch plans for new QIAstat-Dx Rise higher-throughput version

Business Wire January 10, 2022

QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations

Business Wire January 7, 2022

QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB

Business Wire January 6, 2022

Denovo Biopharma and QIAGEN partner to develop companion diagnostic test for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

PR Newswire December 9, 2021

QIAGEN and Denovo Biopharma Partner to Develop Companion Diagnostic Test for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)

Business Wire December 9, 2021

QIAGEN Launches CE-marked Version of QuantiFERON® SARS-CoV-2 to Assess T-cell Response to COVID-19

Business Wire December 2, 2021

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS

Business Wire November 29, 2021

QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529

Business Wire November 26, 2021

QIAGEN Commits to Reduce Carbon Emissions by Setting Science-Based Target to Reach Net Zero by 2050

Business Wire November 8, 2021

QIAGEN and BD Settle Patent Infringement Lawsuit

Business Wire November 5, 2021

QIAGEN Reports Strong Results for Third Quarter and First Nine Months Of 2021

Business Wire November 3, 2021

QIAGEN expands QIAstat-Dx testing menu with respiratory four-plex panel that differentiates between flu, RSV and SARS-CoV-2

Business Wire November 2, 2021

QIAGEN Strengthens UK Footprint With Move to New Manchester Facilities

Business Wire October 22, 2021

QIAGEN N.V. to Release Results for Q3 2021 and First Nine Months of 2021

Business Wire October 20, 2021

QIAGEN Launches Novel QIAreach QuantiFERON-TB Tuberculosis Test for High-Burden Regions

Business Wire October 19, 2021

Quotient Limited Announces Appointment of Chief Commercial Officer

GlobeNewswire October 5, 2021

QIAGEN Receives U.S. Department of Defense Contract to Further Expand Production Capacity for NeuMoDx

Business Wire September 30, 2021

QIAGEN to Enter the DAX - Germany's Leading Stock Market Index

Business Wire September 3, 2021

QIAGEN Reaches Milestone With Its Kits Used to Process More Than Three Billion Biological Samples to Date

Business Wire August 23, 2021

QIAGEN and GT Molecular Collaborate to Offer a Complete SARS-CoV-2 Wastewater Detection Solution Based on QIAcuity Digital PCR Technology

Business Wire August 10, 2021